Panacea Biotec Ltd.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 13242
 
  
 
C07D HETEROCYCLIC COMPOUNDS 5157

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9642808 Extended release compositions comprising mycophenolate sodium and processes thereofAug 11, 08May 09, 17[A61K]
9402808 Liquid oral composition of lanthanum saltsJan 17, 12Aug 02, 16[A61K]
9133116 Bicyclic compoundsSep 27, 11Sep 15, 15[A61K, C07D]
9018249 SGLT inhibitorsSep 12, 12Apr 28, 15[A61K, C07D]
8906913 AzabicyclohexanesJun 22, 10Dec 09, 14[A61K, C07D]
8841306 AntimicrobialsNov 18, 09Sep 23, 14[A61K, C07D]
8551451 Combination vaccine with acellular pertussisOct 23, 09Oct 08, 13[A61K]
8455479 Heterocyclic compoundsJan 23, 09Jun 04, 13[A61K, C07D, A61P]
8277843 Programmable buoyant delivery technologySep 03, 07Oct 02, 12[A61K]
7371412 Pharmaceutical compositions comprising an extract of Euphorbia prostrataDec 31, 04May 13, 08[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0228,303 NOVEL SGLT INHIBITORSAbandonedJun 13, 12Aug 14, 14[A61K, C07H]
2013/0280,324 SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING PREGABALINAbandonedSep 15, 11Oct 24, 13[A61K]
2012/0141,525 UNIVERSAL INFLUENZA VACCINE BASED ON RECOMBINANT MODIFIED VACCINE ANKARA VIRUS (MVA)AbandonedMay 17, 10Jun 07, 12[A61K, C12N, A61P]
2012/0010,158 TUMOR NECROSIS FACTOR INHIBITING PEPTIDES AND USES THEREOFAbandonedNov 05, 09Jan 12, 12[A61K, A61P, C07K]
2011/0268,808 DUAL-RELEASE PHARMACEUTICAL SUSPENSIONAbandonedJan 08, 10Nov 03, 11[A61K, A61P]
2011/0269,680 GLP-1 ANALOGS AND USES THEREOFAbandonedDec 24, 09Nov 03, 11[A61K, A61P, C07K]
2011/0195,087 COMBINATION VACCINE WITH WHOLE CELL PERTUSSISAbandonedOct 23, 09Aug 11, 11[A61K, A61P]
2011/0160,274 FENOFIBRATE FORMULATION WITH ENHANCED ORAL BIOAVAILABILITYAbandonedJun 26, 09Jun 30, 11[A61K, A61P]
7956067 Composition comprising at least one higher aliphatic alcohol and an extract of Griffonia simplicifoliaExpiredMay 09, 07Jun 07, 11[A61K]
2011/0130,434 MODIFIED RELEASE RAMIPRIL COMPOSITIONS AND USES THEREOFAbandonedJul 28, 09Jun 02, 11[A61K, A61P]
2011/0091,536 COMPOSITIONS COMPRISING EUPHORBIA PROSTRATA AND PROCESS OF PREPARATION THEREOFAbandonedMay 28, 09Apr 21, 11[A61K, A61P]
2011/0008,426 MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING MYCOPHENOLATE AND PROCESSES THEREOFAbandonedMar 04, 09Jan 13, 11[A61K, A61P]
2010/0234,288 SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION ON THE BASIS OF RELEASE SYSTEM COMPRISING AN ACID-SOLUBLE POLYMER AND A pH-DEPENDENT POLYMERAbandonedMar 19, 07Sep 16, 10[A61K, A61P]
2010/0204,333 Novel Pharmaceutical Modified Release Dosage Form Cyclooxygenase Enzyme InhibitorAbandonedJul 19, 06Aug 12, 10[A61K, A61P]
2010/0172,993 PARTICLES FOR DELIVERY OF ACTIVE INGREDIENTS, PROCESS OF MAKING AND COMPOSITIONS THEREOFAbandonedAug 10, 07Jul 08, 10[A61K, C07H, A01N, C07D, C07C, A61P, A61Q, C07K]
2010/0166,872 NOVEL IMPROVED COMPOSITIONS FOR CANCER THERAPYAbandonedOct 19, 06Jul 01, 10[A61K, A61P]
2010/0098,735 INJECTABLE DEPOT COMPOSITIONS AND ITS PROCESS OF PREPARATIONAbandonedOct 03, 07Apr 22, 10[A61K, A61P]
2010/0086,592 MODIFIED DOSAGE FORMS OF TACROLIMUSAbandonedMar 25, 08Apr 08, 10[A61K]
2010/0056,493 MODIFIED RELEASE PHARMACEUTICAL COMPOSITION AND A PROCESS OF MAKING THE SAMEAbandonedJan 24, 08Mar 04, 10[A61K]
2010/0015,195 INJECTABLE DEPOT COMPOSITIONS AND IT'S PROCESS OF PREPARATIONAbandonedOct 03, 07Jan 21, 10[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.